Anebulo Pharmaceuticals (ANEB) News Today → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free ANEB Stock Alerts $2.21 -0.15 (-6.36%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 7:02 AM | americanbankingnews.comShort Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Declines By 10.9%May 15 at 11:09 PM | investorplace.comANEB Stock Earnings: Anebulo Pharmaceuticals Beats EPS for Q3 2024May 15 at 7:03 PM | finance.yahoo.comAnebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent UpdatesMay 15 at 1:15 PM | businesswire.comGalehead Development to Collaborate With Rivian Automotive on Renewable Energy Project DevelopmentMay 14 at 4:21 PM | marketbeat.comAnebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Sees Significant Drop in Short InterestAnebulo Pharmaceuticals, Inc. (NASDAQ:ANEB - Get Free Report) saw a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 17,900 shares, a decrease of 10.9% from the April 15th total of 20,100 shares. Currently, 0.2% of the company's shares are short sold. Based on an average daily volume of 5,600 shares, the days-to-cover ratio is currently 3.2 days.April 30, 2024 | marketbeat.comAnebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Sees Significant Increase in Short InterestAnebulo Pharmaceuticals, Inc. (NASDAQ:ANEB - Get Free Report) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 20,100 shares, an increase of 6.9% from the March 31st total of 18,800 shares. Based on an average trading volume of 5,600 shares, the days-to-cover ratio is currently 3.6 days. Currently, 0.2% of the shares of the stock are sold short.April 17, 2024 | morningstar.comAnebulo Pharmaceuticals Inc 214April 10, 2024 | marketbeat.comShort Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Rises By 308.7%Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB - Get Free Report) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 18,800 shares, an increase of 308.7% from the March 15th total of 4,600 shares. Based on an average trading volume of 5,600 shares, the short-interest ratio is currently 3.4 days. Approximately 0.2% of the company's shares are short sold.April 2, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Acrivon Therapeutics, Inc. (ACRV), Abivax SA Sponsored ADR (ABVX)March 18, 2024 | marketbeat.comShort Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Expands By 10.0%Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB - Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 29th, there was short interest totalling 3,300 shares, an increase of 10.0% from the February 14th total of 3,000 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 9,000 shares, the days-to-cover ratio is presently 0.4 days.February 26, 2024 | msn.comMilestone rallies 23% on FDA update for tachycardia drugFebruary 16, 2024 | markets.businessinsider.comAnebulo Pharmaceuticals: Strong Buy Rating Amid Promising Clinical Advances and Rapid FDA TrackFebruary 15, 2024 | msn.comNew Debt & Financing Risk for Anebulo Pharmaceuticals, Inc. – What’s the Latest?February 14, 2024 | msn.comSubstance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication DrugFebruary 14, 2024 | marketbeat.comAnebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Sees Large Decline in Short InterestAnebulo Pharmaceuticals, Inc. (NASDAQ:ANEB - Get Free Report) was the target of a significant decrease in short interest in the month of January. As of January 31st, there was short interest totalling 2,700 shares, a decrease of 18.2% from the January 15th total of 3,300 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average daily volume of 14,400 shares, the short-interest ratio is currently 0.2 days.February 13, 2024 | finance.yahoo.comAnebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent UpdatesFebruary 7, 2024 | marketbeat.comAnebulo Pharmaceuticals (ANEB) to Release Quarterly Earnings on ThursdayAnebulo Pharmaceuticals (NASDAQ:ANEB) will be releasing earnings on Thursday, February 8, Yahoo Finance reports.January 20, 2024 | benzinga.comAnebulo Pharmaceuticals Stock (NASDAQ:ANEB) Dividends: History, Yield and DatesJanuary 8, 2024 | finance.yahoo.comAnebulo Pharmaceuticals, Inc. (ANEB)December 17, 2023 | nasdaq.comAnebulo Pharmaceuticals (FRA:214) Price Target Increased by 21.00% to 6.80December 9, 2023 | morningstar.comAnebulo Pharmaceuticals Inc ANEBNovember 21, 2023 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: 60 Degrees Pharmaceuticals, Inc. (SXTP) and Brainsway (BWAY)November 17, 2023 | markets.businessinsider.comBuy Recommendation for Anebulo Pharmaceuticals: Promising Financial Outlook and Potential Breakthrough in Acute Cannabis Intoxication TreatmentNovember 15, 2023 | msn.comAnebulo Pharmaceuticals GAAP EPS of -$0.10 beats by $0.02November 14, 2023 | finance.yahoo.comAnebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent UpdatesNovember 6, 2023 | finance.yahoo.comHere's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn SituationOctober 19, 2023 | msn.comAre Medical Stocks Lagging Anebulo Pharmaceuticals (ANEB) This Year?October 11, 2023 | benzinga.comDirector at Anebulo Pharmaceuticals Acquires Company Stock Options Worth 26,097 SharesOctober 6, 2023 | marketwatch.comAnebulo Pharmaceuticals Names Richie Cunningham as CEOOctober 6, 2023 | finance.yahoo.comAnebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of DirectorsOctober 6, 2023 | finance.yahoo.comAnebulo Pharmaceuticals Announces New CEOSeptember 25, 2023 | msn.comHC Wainwright & Co. Reiterates Anebulo Pharmaceuticals (ANEB) Buy RecommendationSeptember 25, 2023 | markets.businessinsider.comH.C. Wainwright Sticks to Its Buy Rating for Anebulo Pharmaceuticals (ANEB)September 23, 2023 | nasdaq.comMaxim Group Initiates Coverage of Anebulo Pharmaceuticals (ANEB) with Buy RecommendationSeptember 22, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA), Aurinia Pharmaceuticals (AUPH) and Aquestive Therapeutics (AQST)September 20, 2023 | finance.yahoo.comAnebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent UpdatesSeptember 18, 2023 | msn.comHC Wainwright & Co. Initiates Coverage of Anebulo Pharmaceuticals (ANEB) with Buy RecommendationSeptember 18, 2023 | markets.businessinsider.comSubstance Use Disorder Focused Anebulo Could Be Attractive Acquisition Target, Analyst SaysSeptember 18, 2023 | markets.businessinsider.comAnebulo Pharmaceuticals (ANEB) Has a New Rating from H.C. WainwrightAugust 30, 2023 | finance.yahoo.comAnebulo Pharmaceuticals to Present at Upcoming Investor and Scientific ConferencesAugust 22, 2023 | finance.yahoo.comAnebulo (ANEB) Gains on Positive FDA Response for ANEB-001August 21, 2023 | markets.businessinsider.comAnebulo Pharma: FDA Provides Favorable Input On Studies To Support ANEB-001 ApprovalAugust 21, 2023 | finance.yahoo.comAnebulo Receives Positive Feedback from FDA on Path to Advance Phase 3 Clinical Development of ANEB-001 and Completes Dosing of Phase 2 ExtensionMay 30, 2023 | finance.yahoo.comWe Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Needs To Drive Business Growth CarefullyMay 19, 2023 | finance.yahoo.comDown -26.43% in 4 Weeks, Here's Why You Should You Buy the Dip in Anebulo Pharmaceuticals, Inc. (ANEB)May 18, 2023 | msn.comBenchmark Reiterates Anebulo Pharmaceuticals (ANEB) Speculative Buy RecommendationMay 11, 2023 | finanznachrichten.deAnebulo Pharmaceuticals, Inc.: Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent UpdatesMay 11, 2023 | msn.comAnebulo Pharmaceuticals: Q3 Earnings InsightsMay 11, 2023 | finance.yahoo.comAnebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent UpdatesMarch 29, 2023 | msn.comAntidote For THC? Anebulo Releases Positive Clinical Data Showing Potential Of Its Drug For Treatment Of Acute Cannabinoid Intoxication Get Anebulo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANEB and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. ANEB Media Mentions By Week ANEB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANEB News Sentiment▼1.120.54▲Average Medical News Sentiment ANEB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANEB Articles This Week▼80▲ANEB Articles Average Week Get Anebulo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ANEB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Immix Biopharma News Eledon Pharmaceuticals News Tiziana Life Sciences News Kezar Life Sciences News CalciMedica News Kronos Bio News Carisma Therapeutics News Eagle Pharmaceuticals News Checkpoint Therapeutics News AEON Biopharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANEB) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & CompanyBiden Nomination CANCELED?The Freeport SocietyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 Media348 million Americans lives to END as we know it?The Oxford ClubA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
